Newsroom

Sorted by: Latest

-

Shields Health Solutions Demonstrates Industry Leading Clinical Outcomes

STOUGHTON, Mass.--(BUSINESS WIRE)--Shields Health Solutions (Shields), the nation's leading specialty pharmacy accelerator, released its 2025 Clinical Outcomes Report, detailing exceptional patient outcomes across 12 chronic or complex disease states, including cystic fibrosis, hepatitis C, HIV, inflammatory bowel disease (IBD), multiple sclerosis (MS), oncology, rheumatoid arthritis (RA), and transplant. This year’s report included the addition of four new conditions: diabetes, hyperlipidemia,...
-

IonQ Earns ISO 14001 Certification, Advancing Enterprise-Ready Quantum Innovation

COLLEGE PARK, Md.--(BUSINESS WIRE)--IonQ (NYSE: IONQ), the world’s leading quantum platform company, today announced that its subsidiary, ID Quantique (IDQ), has earned the ISO 14001 Environmental Management System (EMS) certification. With this recognition, IonQ becomes the first pure-play* quantum company to secure ISO 14001, ISO 9001, and ISO 27001 certifications, underscoring its commitment to delivering enterprise-grade quantum solutions that meet global standards for quality, security, an...
-

Bank of America Stadium Readies for 2026 Charlotte FC Season with Renewal of Evolv Express® Subscription, Adds Evolv eXpedite™ Bag Screeners

WALTHAM, Mass.--(BUSINESS WIRE)--Evolv Technologies Holdings, Inc. (NASDAQ: EVLV), a leading security technology company pioneering AI-based solutions designed to create safer experiences, today announced that it has extended and expanded its hardware and software subscription agreement with Bank of America Stadium in Charlotte, North Carolina. The 75,000-seat stadium, which hosts a full annual calendar of Carolina Panthers games, Charlotte FC matches, concerts, and other events, originally dep...
-

Delcath Systems Announces Publication of CHOPIN Clinical Trial Results in The Lancet Oncology

QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH), (“Delcath” or the “Company”) an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced the publication of the full results from the investigator-initiated CHOPIN randomized Phase 2 clinical trial, led by Principal Investigator Professor Ellen Kapiteijn, MD, from Leiden University Medical Center’s Department of Medical Oncology. The publication, titled “Percutaneous...
-

Irvine Dream Run Back in Great Park This May 9

IRVINE, Calif.--(BUSINESS WIRE)--The Irvine Dream Run sponsored by American Lending Center Holdings Inc., (ALC) and Sunstone Investment Group is back for another year at the Great Park in Irvine. Dream Run day is Saturday, May 9. This is the third year for the 5K and 3K, which celebrates the entrepreneurial community in and around Irvine. More than 1,000 runners are expected to participate this year, and signups have already begun. Organizers see the Irvine Dream Run as an opportunity to build...
-

American Beacon Partners Appoints Patti Barron as Chief Transformation Officer

IRVING, Texas--(BUSINESS WIRE)--American Beacon Partners continues to add to senior leadership, names Patti Barron Chief Transformation Officer....
-

Surescripts Annual Impact Report Shows Collaboration, Innovation Gains in Interoperability, Prior Authorization Automation and Medication Access in 2025

ARLINGTON, Va.--(BUSINESS WIRE)--Surescripts®, the nation’s leading health intelligence network, today released its Annual Impact Report 2025, highlighting record advancements in health data interoperability, enhanced efficiency for care providers, and faster, more affordable access to prescription therapy for patients nationwide. New Data: Surescripts Annual Impact Report 2025 “When we talk about advancing healthcare interoperability, we are talking about strengthening the connection between p...
-

Kivu Bioscience Appoints Brunilda Shtylla as Chief Business Officer

SAN MATEO, Calif.--(BUSINESS WIRE)--Kivu Bioscience Appoints Brunilda Shtylla as Chief Business Officer...
-

O2 Investment Partners Closes Oversubscribed Fund V at $670 Million

BLOOMFIELD HILLS, Mich.--(BUSINESS WIRE)--O2 Investment Partners, LP announces the final closing of O2 Investment Partners Fund V with $670 million in capital commitments....
-

Aspen Standard Wealth Acquires $1 Billion AUM RIA BlueSky Wealth Advisors

NEW YORK--(BUSINESS WIRE)--Aspen Standard Wealth, LLC (“Aspen”), a permanent home for successful independent RIAs, announced today that it has acquired BlueSky Wealth Advisors, LLC (“BlueSky”) a New Bern, N.C.,-based RIA with $1 billion in assets under management (“AUM”). Founded in 1999, BlueSky is a fee-only, independent financial advisory firm that provides a highly personalized blend of investment management and comprehensive financial planning with the goal of helping clients develop tax m...